Erasca Inc. Common Stock vs iShares MSCI United Kingdom (FTSE) — how do they compare? Erasca Inc. Common Stock trades at $16.03 (market cap $5.40B), while iShares MSCI United Kingdom (FTSE) trades at $46.52 (market cap $3.62B). The key difference: Erasca Inc. Common Stock is the larger of the two by market cap, and iShares MSCI United Kingdom (FTSE) is more actively traded (923,896 versus 9,533,185). Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and iShares MSCI United Kingdom (FTSE) for 46 Days on average.
| ERAS | EWU | |
|---|---|---|
Market Cap | $5.40B | $3.62B |
Volume | 9,533,185 | 923,896 |
Sector | Health | Broad Market / Factor |
52-Week High | $22.47 | $49.39 |
52-Week Low | $2.20 | $41.34 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $5.18B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EWU trades at $46.23, up 0.65% on the day, but faces a bearish technical outlook with 16 sell signals versus 3 buy signals. The stock is testing key support at $46 amid rising UK gilt yields and inflation concerns. Recent UK housing policy announcements have boosted related sectors, but broader European economic pressures and ECB rate hikes create headwinds for the UK-focused ETF.
The outlook remains cautious given technical weakness and macroeconomic pressures from rising interest rates and energy prices. Investment opportunity exists if housing stimulus gains traction, but risks include prolonged inflation and further ECB tightening that could pressure UK equities.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →